GILD
$159.08+0.25%
as of close, Oct 27, 2026
☾ AH $159.08 +0.25%
GILD — Gilead Sciences Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
60.070.080.090.0100.0110.0120.0130.0140.0150.00100.0M200.0M$159.08—20162019202120242026
2026-10-27
Price$159.08
MA20$139.08
MA50$133.11
Vol23.3M
Key stats#
Price data
- Price
- $159.08
- YTD price return
- +29.61%
- YTD total return
- +31.94%
- Next earnings
- Oct 29, 2026 · After close
- Market cap
- 197.3B
- Enterprise value
- 220.8B
- Shares outstanding
- 1.2B
- 52W low
- $114.02
- 52W high
- $160.51
- From 52W high
- -0.89%
- From 52W low
- +39.52%
- 52W range
- 97%
- Beta
- 0.32
Volume
- Rel volume
- 0.81×
- 30D volume
- 6.1M
- 30D $ vol
- 922.1M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$3.2M
- Insider net 3M
- −$15.9M
- Insider net 1Y
- −$71.7M
Form 4 transactions by trade date, as filed; latest on file 2026-10-15.
Fundamentals
- Sales (ttm)
- 30.5B
- Sales/share
- $24.56
- EPS (ttm)
- -$2.59
- FCF (ttm)
- 12.9B
- FCF/share
- $10.44
- Book value/share
- $9.54
- Net margin
- -10.64%
- ROE
- -27.39%
- ROA
- -6.56%
- Debt / equity
- 2.01×
- Current ratio
- 1.27
Growth (CAGR, ttm) · 10Y
- Sales
- +5.53%+3.61%+2.72%-0.61%
- FCF
- +38.18%+13.18%+8.85%-3.34%
- Shares
- -0.07%-0.16%-0.22%-0.62%
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +5.60%+3.78%+2.94%+0.01%
- FCF/share
- +38.27%+13.37%+9.09%-2.73%
- Book value/share
- -39.85%-17.48%-9.50%-2.08%
- Dividend/share
- +3.21%+2.85%+2.98%+6.23%
- Price
- +32.07%+27.57%+18.96%+7.75%
- Total return
- +35.34%+31.65%+23.28%+11.63%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -61.4×
- P/OI (ttm)
- 15.1×
- Fwd P/E
- 15.6×
- P/S (ttm)
- 6.5×
- P/B (mrq)
- 16.7×
- P/FCF (ttm)
- 15.2×
- EV/EBITDA (fy)
- 806.0×
- EV/Sales (ttm)
- 7.3×
- FCF yield (ttm)
- 6.56%
- Dividend yield (fwd)
- 2.06%
- Dividend yield (ttm)
- 2.04%
- Dividend/share (fwd)
- $3.28
- Buyback yield (realized, 1y)
- 0.07%
- Shareholder yield (realized, 1y)
- 3.03%
- Buyback yield (cash, ttm)
- 0.58%
- Shareholder yield (cash, ttm)
- 2.64%
Vs own 10Y history
- P/E
- 34th
- P/OI
- 62nd
- P/S
- 100th
- P/B
- 100th
- P/FCF
- 92nd
Bar = where today’s multiple sits in GILD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
+0.25%
5D
+1.64%
1M
+5.40%
3M
+21.88%
YTD
+29.61%
1Y
+32.05%
5Y
+138.25%
Recent filings#
- Aug 4Earnings · Earnings release — EPS −$6.75 vs −$7.07 est. (+4.5%); revenue $7.80B (+10% y/y) 2.6%
Financial statements
Open full GILD financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
